BayWa AG Reports Extraordinary Depreciation of €222.2 Million Following Impairment Tests

BayWa AG has announced extraordinary depreciation amounting to €222.2 million, as revealed in their Half-Year Financial Statements 2024. This write-down follows mandatory impairment tests conducted in accordance with IAS 36.

The largest part of this depreciation, totalling €171.5 million, is attributed to BayWa r.e. AG, a 51% subsidiary of BayWa AG. Despite these impairments, the ongoing restructuring efforts and the execution of the restructuring plan currently being formulated will not be negatively affected.

The complete Half-Year Financial Statements 2024 will be available today on the BayWa Group's website.

For more details, please contact Josko Radeljic, Head of Investor Relations at BayWa AG, via telephone at +49 (0)89/92 22-38 87 or email at josko.radeljic@baywa.de.